30 completed, 7 unknown. 12 Not applicable, 8 Phase 4, 7 Phase 3, 6 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Not applicable | 12 | Completed 10, Unknown 2 |
| Phase 4 | 8 | Completed 8 |
| Phase 3 | 7 | Completed 6, Unknown 1 |
| Phase 2 | 6 | Completed 4, Unknown 2 |
Follow Centre Muraz: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| The TRIple Elimination Model Of Mother-to-child Transmission Program (TRI-MOM) TRI-MOM intervention - Hiv, Syphilis | Not applicable | Unknown | Institut de Recherche pour le Developpement | 2800 | 2024-03-18 | 2024-06-20 |
| Description and Comparison of Biological Vulnerability in Small Vulnerable Newborns Versus Healthy Community Controls in Urban Burkina Faso Preterm Birth, Low Birth Weight | Unknown | University Ghent | 140 | 2023-01-09 | 2024-05-31 | |
| Effectiveness of Four Transition Dietary Regimens in the Hospital Management of Children With Kwashiorkor. Standard F100, Standard F75 + Plumpynut, Alternative F75 with CMV + Plumpynut - Severe Acute Malnutrition, Kwashiorkor | Not applicable | Completed | University Ghent | 32 | 2021-09-15 | 2023-10-03 |
| Effectiveness of Alternative Diets During the Stabilization Phase on Children With Complicated SAM Standard F75, Alternative F75 with CMV, Alternative F75 without CMV - Severe Acute Malnutrition, Kwashiorkor | Not applicable | Completed | University Ghent | 297 | 2021-09-15 | 2023-10-30 |
| Dietary Rehabilitation in Severely Acutely Malnourished Children Standard F75, Alternative F75 With CMV, Alternative F75 Without CMV - Severe Acute Malnutrition, Kwashiorkor | Completed | University Ghent | 1959 | 2021-08-10 | 2023-11-18 | |
| Early Treatment of Vulnerable Individuals With Non-Severe SARS-CoV-2 Infection Nitazoxanide and Ciclésonide, Telmisartan 20Mg Oral Tablet, Paracetamol - Covid19, Covid19 Drug Treatment | Phase 2 / Phase 3 | Unknown | ANRS, Emerging Infectious Diseases | 600 | 2021-04-12 | 2023-01-31 |
| Neovac 2 Burkina Faso: Impact of the Integration of Hepatitis B Birth Dose Vaccine Into the Infant Immunization Schedule birth dose vaccination against hepatitis B strategy - Hepatitis B | Not applicable | Completed | Institut Pasteur | 10000 | 2020-10-19 | 2023-12-19 |
| Cross Sectional Survey on the Burden, Impacts and Causes of Hepatitis C Virus (HCV) Outbreak in South West Region in Burkina Faso Hepatitis C Virus Infection, Past or Present, Chronic Hepatitis c | Unknown | ANRS, Emerging Infectious Diseases | 3300 | 2020-07-14 | 2021-04-19 | |
| An Observational Study to Assess the Protocol for the COVID-19 Treatment in Burkina Faso Coronavirus Infection | Completed | Centre Muraz | 153 | 2020-04-24 | 2021-01-22 | |
| Prevention of Mother-to-child Transmission of HIV-1 Using a Responsive Intervention Lamivudine Oral Solution - HIV-1 | Phase 3 | Completed | ANRS, Emerging Infectious Diseases | 1506 | 2019-12-14 | 2022-12-07 |
| Preventing Childhood HIV: Rescue Intervention. ANRS 12388 PREVENIR-PEV Lamivudine Oral Solution - HIV-1 | Phase 2 | Unknown | ANRS, Emerging Infectious Diseases | 97 | 2019-12-04 | 2022-03-31 |
| African-Canadian Study of HIV-Infected Adults and a Vaccine for Ebola - ACHIV-Ebola V920 (rVSVΔG-ZEBOV-GP) Ebola Virus Vaccine, Saline - Ebola | Phase 2 | Completed | Canadian Immunization Research Network | 251 | 2017-08-01 | 2026-01-12 |
| Safety, Tolerability and Immunogenicity Study of 3 Prime-boost Regimens for Ebola Vaccines Ad26.ZEBOV/MVA-BN-Filo in Healthy Adults, Children and Human Immunodeficiency Virus Positive (HIV+) Adults Ad26.ZEBOV, MVA-BN-Filo, Placebo - Hemorrhagic Fever, Ebola | Phase 2 | Completed | Janssen Vaccines & Prevention B.V. | 1075 | 2015-11-06 | 2022-03-07 |
| Repeat Ivermectin Mass Drug Administrations for Control of Malaria: a Pilot Safety and Efficacy Study Ivermectin, Albendazole - Malaria, Lymphatic Filariasis | Phase 2 / Phase 3 | Completed | Colorado State University | 2712 | 2015-06-01 | 2019-01-04 |
| Alive & Thrive Evaluation in Burkina Faso A&T infant and young child feeding intervention - Breast Feeding, Breast Feeding, Exclusive | Not applicable | Completed | London School of Hygiene and Tropical Medicine | 4541 | 2015-06-01 | 2018-12-04 |
| Early Antiretroviral Therapy and Pre-exposure Prophylaxis for HIV Prevention Among Female Sex Workers in Cotonou, Benin TasP using ART regimen as per Benin guidelines, PrEP using Truvada - Adherence to Medication Regime | Phase 4 | Completed | CHU de Quebec-Universite Laval | 361 | 2014-10-01 | 2017-07-19 |
| A Trial of an Integrated E-diagnosis Assessment to Improve the Management of Childhood Illnesses in Burkina Faso integrated ediagnostic approach (IeDA) - IMCI Guidelines, Childhood Illnesses | Not applicable | Completed | London School of Hygiene and Tropical Medicine | 7200 | 2014-09-01 | 2018-01-11 |
| Community-based Screening and Treatment of Malaria in Pregnancy: a Cluster-randomized Trial community based screening and treatment - Malaria, Antepartum, Maternal Malaria During Pregnancy - Baby Not Yet Delivered | Not applicable | Completed | Royal Tropical Institute | 4265 | 2013-10-01 | 2016-10-04 |
| Saving Brain in Uganda and Burkina Faso Peer support for exclusive breastfeeding - Poor Performance Status, Neurologic Deficits | Not applicable | Unknown | Makerere University | 600 | 2013-04-01 | 2013-08-02 |
| Amodiaquine-Artesunate & Artemether-Lumefantrine Efficacy in Burkina Faso Amodiaquine-Artesunate, Artemether-lumefantrine - Malaria | Phase 4 | Completed | Centre Muraz | 150 | 2012-10-01 | 2015-07-31 |
Showing 20 of 37. Sign in to see all of them.
Malaria (12) · Kwashiorkor (3) · Severe Acute Malnutrition (3) · Breast Feeding (2) · Diarrhea (2) · Disease (2) · Hemorrhagic Fever, Ebola (2) · Hepatitis B (2) · Malaria, Falciparum (2) · Protein-Energy Malnutrition (2) · Acquired Immunodeficiency Syndrome (1) · Anemia (1) · Birth Weight (1) · COVID-19 (1) · Coronavirus Infections (1)
Artemether, Lumefantrine Drug Combination (7) · amodiaquine, artesunate drug combination (7) · Folic Acid (2) · Iron (2) · Lamivudine (2) · Acetaminophen (1) · Albendazole (1) · Artesunate (1) · Chloroquine (1) · Clindamycin (1) · Community Health Workers (1) · Ebola Vaccines (1) · Emtricitabine (1) · Fluoxetine (1) · Ivermectin (1)
Burkina Faso (32) · Uganda (5) · Zambia (4) · Benin (2) · The Gambia (2) · Cambodia (1) · Cameroon (1) · Canada (1) · Côte d’Ivoire (1) · Gabon (1) · Ghana (1) · Guinea (1) · Kenya (1) · Malawi (1) · Mozambique (1)
Bintou Sanogo, MSc. Md. (3) · Halidou Tinto, PharmD, PhD (3) · Jerome Some, Md. PhD (3) · Souheila Abbeddou, MSc. PhD (3) · Stefaan De Henauw, Md. PhD (3) · Halidou Tinto, PhD (2) · Philippe Van de Perre, MD, PhD (2) · Umberto D'Alessandro, MD (2) · Brian D. Foy, PhD (1) · Carl Lachat, MEng, PhD (1) · Carolyn Nabasumba, M.B.Ch.B (1) · Cecile Tremblay, MD (1) · Dominique Roberfroid, MD (1) · Henk Schallig, Dr (1)
PMID 18996870, PMID 20375185, PMID 20716352, PMID 21367950, PMID 21372798, PMID 21573019, PMID 21752462, PMID 21760916, PMID 22087077, PMID 22298571, PMID 22378724, PMID 22827969, PMID 22947029, PMID 23088827, PMID 23384876, PMID 24059911, PMID 24427264, PMID 24891429, PMID 24950759, PMID 25053420, PMID 25592254, PMID 25684587, PMID 25784955, PMID 25938681, PMID 26088768, PMID 26289949, PMID 26637464, PMID 26908804, PMID 26962727, PMID 27031231, PMID 27280792, PMID 27405396, PMID 27473676, PMID 27488566, PMID 27840069, PMID 27895848, PMID 28631283, PMID 29166928, PMID 29174612, PMID 29433668, PMID 29474479, PMID 29540225, PMID 29733403, PMID 29961848, PMID 30057798, PMID 30384846, PMID 30689814, PMID 30737046, PMID 30784636, PMID 30878222
2019 (1), U01HD061234 (1)